Drug Type Small molecule drug |
Synonyms MK 4409 |
Target |
Action inhibitors |
Mechanism FAAH inhibitors(Anandamide amidohydrolase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H17ClFN3O2S |
InChIKeyDBZMCSVIITXLCC-UHFFFAOYSA-N |
CAS Registry1207745-58-1 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pain | Phase 1 | United States | - | |
| Pain | Phase 1 | - | - | |
| Inflammatory pain | Preclinical | United States | 14 Apr 2014 | |
| Neuralgia | Preclinical | United States | 14 Apr 2014 |





